Aurobindo’s arm, Acrotech Biopharma, launches Adquey in US - The HinduBusinessLine ... market and expands the company ... s commercial presence ... Acrotech Biopharma, a subsidiary of Aurobindo Pharma, has launched Adquey in the U.S.

Aurobindo’s arm, Acrotech Biopharma, launches Adquey in US - The HinduBusinessLine ... market and expands the company ... s commercial presence ... Acrotech Biopharma, a subsidiary of Aurobindo Pharma, has launched Adquey in the U.S.

Aurobindo Pharma launched Adquey, its first novel drug in the US market, which is used to treat mild-to-moderate atopic dermatitis in adults and children aged two years and above.

Aurobindo Pharma's biopharmaceutical arm Acrotech Biopharma Inc. has launched ADQUEY (difamilast 1%) ointment in the US for the treatment of mild-to-moderate atopic dermatitis in adults and paediatric patients aged 2 years and older.